Skip to content
healthcare.dev

Matzim LA

NDC 52544-692, Diltiazem Hydrochloride, tablet, extended release, from Actavis Pharma, Inc..

Product NDC
52544-692
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077686
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52544-692 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DILTIAZEM HYDROCHLORIDE240 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
52544-692-195254406921990 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-692-19)
52544-692-305254406923030 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-692-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e8c8dd18-9d95-4068-9762-bec1eb1bc25c
  • NADAC price for package 52544069219

    GET /v1/drugs/nadac/52544069219
  • NADAC price for package 52544069230

    GET /v1/drugs/nadac/52544069230

Use it

Look up 52544-692 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52544-692 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52544-692. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.